Division of Cardiovascular Medicine, B Padeh Medical Center, Poriya, Lower Galilee 15208, Israel; The Azrieli Faculty of Medicine in the Galilee, Bar-Ilan University, Safed 1311502, Israel.
The Azrieli Faculty of Medicine in the Galilee, Bar-Ilan University, Safed 1311502, Israel; Oral Medicine Unit, B Padeh Medical Center, Poriya, Lower Galilee 15208, Israel.
Int J Cardiol. 2019 Nov 1;294:23-26. doi: 10.1016/j.ijcard.2019.07.081. Epub 2019 Jul 26.
40% of cases of infective endocarditis (IE) are likely caused by oral bacteria. IE prevalence after transcatheter aortic valve replacement (TAVR) is comparable to IE following surgical prosthetic valve replacement (SVR). Current guidelines recommend pre-operative dental screening for SVR, without specific recommendations regarding TAVR. We aimed to compare oral dental findings in TAVR vs. surgical valve replacement (SVR) candidates and assess the need for routine dental screening and treatment prior to TAVR similar to the SVR patients.
150 patients (58 TAVR candidates and 92 surgical candidates) were all referred for screening and appropriate treatment before intervention to our Oral medicine team, blinded to the planned interventional type. All patients were scored for oral hygiene and dental findings that required intervention. An oral health score (OHS, general hygiene: 0-good, 1-bad, need for immediate treatment: 0-no, 1-yes, need for future treatment: 0-no, 1-yes) was calculated and compared. Patients were clinically followed for IE for 14 ± 5 months (rage 8-28) post intervention.
While candidates for SVR were younger than TAVR (66 + 10 vs. 81 ± 6 respectively, P < 0.0001), oral-dental findings were similar. OHS was 1.6 for SVR and 1.7 for TAVR candidates, p = 0.45). Half of patients in either group had findings requiring pre-procedural dental treatment. There were two IE cases during follow-up, one in each group.
Oral health and need for pre-procedural dental treatment were not different among candidates for SVR and TAVR. IE preventive oral-dental care seems to be justified in patients undergoing TAVR initially denied SVR due to prohibitive operative risk.
40%的感染性心内膜炎(IE)病例可能由口腔细菌引起。经导管主动脉瓣置换术(TAVR)后 IE 的发生率与外科人工瓣膜置换术(SVR)后相似。目前的指南建议对 SVR 进行术前牙科筛查,但对 TAVR 没有具体建议。我们旨在比较 TAVR 与外科瓣膜置换术(SVR)患者的口腔牙科发现,并评估在 TAVR 前是否需要常规的牙科筛查和治疗,类似于 SVR 患者。
150 名患者(58 名 TAVR 候选人和 92 名外科候选者)均因干预前的筛查和适当治疗而被转介至我们的口腔医学团队,对计划的干预类型不知情。所有患者的口腔卫生和需要干预的牙科发现均进行评分。计算并比较口腔健康评分(OHS,总体卫生:0-良好,1-差,需要立即治疗:0-否,1-是,需要未来治疗:0-否,1-是)。患者在干预后 14±5 个月(范围 8-28 个月)进行 IE 的临床随访。
虽然 SVR 候选者比 TAVR 候选者年轻(66±10 岁比 81±6 岁,P<0.0001),但口腔牙科发现相似。SVR 和 TAVR 候选者的 OHS 分别为 1.6 和 1.7,p=0.45)。两组各有一半的患者有需要术前牙科治疗的发现。在随访期间发生了两例 IE 病例,每组一例。
在 SVR 和 TAVR 候选者中,口腔健康和术前牙科治疗的需求没有差异。对于最初因手术风险过高而被拒绝 SVR 的接受 TAVR 的患者,预防性口腔牙科护理似乎是合理的。